The COVID-19 pandemic, which was ongoing between 2020 and 2023 and was caused by the SARS-CoV-2 virus, came with risks and consequences not only for the physical but also for the mental health. The pandemic, along with the efforts to reduce viral transmission, had far-reaching consequences at global, societal, and individual levels, including the emergence and exacerbation of various psychological symptoms. Cognitive behavioral therapy (CBT) has previously demonstrated to be effective across a wide range of psychopathologies, including when the treatment is delivered via the internet. Internet-based CBT (ICBT) has been shown to be helpful with outcomes comparable to those of face-to-face CBT when therapist support is included. ICBT may represent a particularly suitable alternative for psychological treatment during the COVID-19 pandemic, as it does not entail an increased risk of viral transmission. However, ICBT had not previously been evaluated within a pandemic-related context, with the unique challenges and consequences such a context implies.
The aims of this thesis were to investigate individually tailored ICBT with weekly therapist support during the COVID-19 pandemic, as well as participants’ experiences of undergoing ICBT during this global crisis. Four studies were conducted to address these aims, three treatment studies and one interview study.
Study I was a pilot randomized controlled trial conducted during the early phase of the COVID-19 pandemic. Participants were randomized to either seven weeks of individually tailored ICBT with weekly therapist support or to a waitlist control condition. Participants in the treatment group received seven individually selected modules out of 16 possible based on their psychological symptoms and problem description. The results indicated that depressive symptoms decreased more in the treatment group compared to the control group over the treatment period. At the same time, no difference in quality of life was observed. Symptoms of anxiety and stress, however, also decreased to a greater extent in the treatment group.
Study II aimed to evaluate the same intervention, this time during the middle phase of the pandemic. Participants in the treatment group received eight individually selected modules over eight weeks. The results from Study I were replicated with shown effects on depressive symptoms, while no improvements were found in quality of life. However, reductions in symptoms of insomnia and anger were observed. At the one-year follow-up, the decrease in insomnia symptoms and anger was shown to be maintained, while the depressive symptoms had decreased even further.
Study III consisted of interviews with participants from Study I, conducted four or six months after treatment completion (depending on whether participants had initially been randomized to the treatment or control group). The aim was to explore participants’ experiences of undergoing individually tailored ICBT during the COVID-19 pandemic. Data were analyzed using thematic analysis and the following four main themes (with ten subthemes) were identified: Functions of the treatment (Initiating and motivating, Perspective widening), Treatment equals work (Experience of the treatment as demanding, Going from text to action, Posttreatment engagement, Participant agency), Changes experienced (Changes in relation to the COVID-19 pandemic, Other changes not related to the COVID-19 pandemic), Wishing for something else (Individually tailored, Contact with the therapist).
Study IV sought to investigate individually tailored ICBT during the final phase of the pandemic, when many of the consequences and public health measures to reduce viral transmission had subsided. The same treatment protocol as in Studies I and II was employed, with the addition of four new modules developed to target psychological needs that may have arisen during the later phase of the pandemic. Due to a limited sample size, a within-group design was used, in which all participants received the treatment simultaneously. Of the 24 participants included, 16 (66.7%) were assessed as likely to meet criteria for post-COVID syndrome. Results showed a reduction in depressive and anxiety symptoms from pre- to post-treatment measurement. Again, no significant improvements were observed in quality of life. However, symptoms of loneliness and fatigue, among others, decreased.
In conclusion, this thesis suggests that individually tailored ICBT with weekly therapist support may be a helpful intervention during the early, middle, and later phases of the COVID-19 pandemic for several psychological symptoms. However, no significant effects on quality of life were observed. Symptom reductions appeared to be maintained during the later phase of the pandemic. Participants’ experiences of undergoing the treatment were largely similar to those described in corresponding studies conducted prior to the pandemic and it was found that changes attributed to the treatment were perceived as related not only to the pandemic context but also to other factors.
Taken together, these findings indicate that ICBT may be a feasible and appropriate treatment option during the COVID-19 pandemic. With further studies, the opportunities with ICBT could potentially be shown during other pandemics or large-scale crises, with similar or perhaps distinct consequences. There is also a need for continued research into mechanisms of change in treatment, including whether these may differ in a pandemic versus non-pandemic context, and how individuals with ongoing psychological symptoms – particularly, but not exclusively, related to post-COVID syndrome – can be supported after the official end of the pandemic.
Until such knowledge is available, this thesis demonstrates that psychological treatment, specifically ICBT, can be helpful in extraordinary contexts and does not need to be postponed until after the end of a global crisis in order to be helpful.